Fort Collins, CO (PRWEB) April 10, 2009
InVitria's line of high performance cell culture media components used for mammalian cell culture will be showcased at the upcoming Williamsburg BioProcessing Foundation The Waterside Conference on April 20-22, 2009, in South San Francisco.
Regarded as one of the leading events addressing scale-up and production issues facing the bioprocessing industry, the 2009 Waterside Conference comes at an opportune time for InVitria to share its product advantages with commercial biomanufacturers.
InVitria's Cellastim (recombinant human serum albumin) and Lacromin (recombinant Lactoferrin) have been used by large-scale commercial manufacturers to significantly improve CHO cell growth and productivity. Cellastim also increases hybridoma cell growth and monoclonal antibody production.
InVitria's Director of Cell Culture, Dr. Steve Pettit, will present two posters at the conference revealing the optimization benefits of InVitria's Cellastim in CHO and hybridoma cell lines. "Recent research from our own work and that of customers shows substantial improvements in the speed of cell line development and seed-train expansion using InVitria's recombinant product," said Dr. Pettit. "This is especially important for our customers who want to eliminate animal-derived components and also expedite their product development process," he continued.
"We are glad to partner with WilBio as a sponsor for this industry-leading event," commented Scott Deeter, InVitria President and CEO. "At The Waterside Conference, we invite existing and new customers to visit our booth to learn how InVitria can help you optimize productivity, reduce product development time and achieve your regulatory objectives."
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.
For more information about InVitria's products, please contact us by e-mail or phone.